Related references
Note: Only part of the references are listed.Punding in Patients on Dopamine Agonists for Restless Leg Syndrome
Andrew H. Evans et al.
MOVEMENT DISORDERS (2009)
Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial
M. Hornyak et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Restless legs syndrome as side effect of second generation antidepressants
Klaus G. Rottach et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome:: a randomised, double-blind, placebo-controlled trial
Claudia Trenkwalder et al.
LANCET NEUROLOGY (2008)
Treatment of Restless Legs Syndrome: An Evidence-Based Review and Implications for Clinical Practice
Clauder Trenkwalder et al.
MOVEMENT DISORDERS (2008)
Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13
David Kemlink et al.
NEUROGENETICS (2008)
Low-dose hydrocortisone in the evening modulates symptom severity in restless legs syndrome
M. Hornyak et al.
NEUROLOGY (2008)
Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome
S. Quilici et al.
SLEEP MEDICINE (2008)
Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
Wolfgang H. Oertel et al.
SLEEP MEDICINE (2008)
A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome
Diego Garcia-Borreguero et al.
SLEEP MEDICINE (2007)
A genetic risk factor for periodic limb movements in sleep
Hreinn Stefansson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions
Juliane Winkelmann et al.
NATURE GENETICS (2007)
First night efficacy of pramipexole in restless legs syndrome and periodic leg movements
Mauro Manconi et al.
SLEEP MEDICINE (2007)
Validation of the Augmentation Severity Rating Scale (ASRS):: A multicentric, prospective study with levodopa on restless legs syndrome
Diego Garcia-Borreguero et al.
SLEEP MEDICINE (2007)
Diagnostic standards for dopaminergic augmentation of restless legs syndrome:: Report from a World Association of Sleep Medicine -: International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute
Diego Garcia-Borreguero et al.
SLEEP MEDICINE (2007)
Restless legs syndrome associated with peripheral neuropathy
F. Gemignani et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Nocturnal blood pressure changes in patients with restless legs syndrome
M. H. Pennestri et al.
NEUROLOGY (2007)
Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis
Andrew H. Evans
MOVEMENT DISORDERS (2007)
Augmentation of restless legs syndrome with long-term tramadol treatment
Roberto Vetrugno et al.
MOVEMENT DISORDERS (2007)
Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists
M. Tippmann-Peikert et al.
NEUROLOGY (2007)
Efficacy of pramipexole in restless legs syndrome:: A six-week, multicenter, randomized, double-blind study (effect-RLS study)
Wolfgang H. Oertel et al.
MOVEMENT DISORDERS (2007)
Dopamine agonists and the risk of cardiac-valve regurgitation
Rene Schade et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
Renzo Zanettini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Pathological gambling associated with dopamine agonist use in restless legs syndrome
Jeremy Quickfall et al.
PARKINSONISM & RELATED DISORDERS (2007)
State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome
Wolfgang H. Oertel et al.
MOVEMENT DISORDERS (2007)
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease
Angelo Antonini et al.
LANCET NEUROLOGY (2007)
Long-term treatment with pramipexole in restless legs syndrome
J. Montplaisir et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort
John W. Winkelman et al.
SLEEP MEDICINE (2006)
EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep
L. Vignatelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome
Walter Paulus et al.
LANCET NEUROLOGY (2006)
Restless legs syndrome augmentation associated with tramadol
Christopher J. Earley et al.
SLEEP MEDICINE (2006)
Exercise and restless legs syndrome: A randomized controlled trial
Melissa McManama Aukerman et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2006)
Validation of the L-DOPA test for diagnosis of restless legs syndrome
Karin Stiasny-Kolster et al.
MOVEMENT DISORDERS (2006)
Restless legs syndrome - Revisiting the dopamine hypothesis from the spinal cord perspective
Stefan Clemens et al.
NEUROLOGY (2006)
Nocturnal eating: Sleep-related eating disorder or night eating syndrome? A videopolysomnographic study
Roberto Vetrugno et al.
SLEEP (2006)
Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome
Jens Carsten Moeller et al.
SLEEP MEDICINE (2006)
Treatment of depression in patients with restless legs syndrome: What is evidence-based?
Magdolna Hornyak et al.
SLEEP MEDICINE (2006)
The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG)
M Zucconi et al.
SLEEP MEDICINE (2006)
Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial
Jacques Montplaisir et al.
MOVEMENT DISORDERS (2006)
Epidemiology of restless legs syndrome: The current status
Diego Garcia-Borregueroa et al.
SLEEP MEDICINE REVIEWS (2006)
The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: An open-label trial
Giovanni Merlino et al.
NEUROPSYCHOBIOLOGY (2006)
Antidepressant medication use and restless legs syndrome in patients presenting with insomnia
LK Brown et al.
SLEEP MEDICINE (2005)
Restless legs syndrome prevalence and impact - REST general population study
RP Allen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Methadone for refractory restless legs syndrome
WG Ondo
MOVEMENT DISORDERS (2005)
Restless legs syndrome in patients after renal transplantation
MZ Molnar et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study
W Hening et al.
SLEEP MEDICINE (2004)
Restless legs syndrome in end-stage renal disease
GL Gigli et al.
SLEEP MEDICINE (2004)
Circadian rhythm of restless legs syndrome: Relationship with biological markers
M Michaud et al.
ANNALS OF NEUROLOGY (2004)
Effective cabergoline treatment in idiopathic restless legs syndrome
K Stiasny-Kolster et al.
NEUROLOGY (2004)
Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome
R Allen et al.
SLEEP (2004)
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome:: A double-blind, placebo-controlled pilot study
K Stiasny-Kolster et al.
MOVEMENT DISORDERS (2004)
Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)
JW Winkelman et al.
SLEEP MEDICINE (2004)
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome
AS Walters et al.
SLEEP MEDICINE (2003)
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health
RP Allen et al.
SLEEP MEDICINE (2003)
Pramipexole in the management of restless legs syndrome: An extended study
MH Silber et al.
SLEEP (2003)
Cabergoline is an effective single-drug treatment for restless legs syndrome: Clinical and actigraphic evaluation
M Zucconi et al.
SLEEP (2003)
Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome
S Happe et al.
NEUROPSYCHOBIOLOGY (2003)
Treatment of restless legs syndrome with gabapentin - A double-blind, cross-over study
D Garcia-Borreguero et al.
NEUROLOGY (2002)
Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families
J Winkelmann et al.
ANNALS OF NEUROLOGY (2002)
Prevalence of restless legs syndrome and periodic limb movement disorder in the general population
MM Ohayon et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
Melatonin-dopamine interactions: From basic neurochemistry to a clinical setting
N Zisapel
CELLULAR AND MOLECULAR NEUROBIOLOGY (2001)
Long-term follow-up on restless legs syndrome patients treated with opioids
AS Walters et al.
MOVEMENT DISORDERS (2001)
Prevalence of restless legs syndrome among men aged 18 to 64 years:: An association with somatic disease and neuropsychiatric symptoms
J Ulfberg et al.
MOVEMENT DISORDERS (2001)
Pleuropulmonary disease due to pergolide use for restless legs syndrome
SK Danoff et al.
CHEST (2001)
Long-term effects of pergolide in the treatment of restless legs syndrome
K Stiasny et al.
NEUROLOGY (2001)
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole 1. Findings on objective and subjective sleep and awakening quality
B Saletu et al.
NEUROPSYCHOBIOLOGY (2000)
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole 2. Findings on periodic leg movement, arousals and respiratory variables
M Saletu et al.
NEUROPSYCHOBIOLOGY (2000)